Literature DB >> 22331871

Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors.

Femke S den Boon1, Pascal Chameau, Qiluan Schaafsma-Zhao, Willem van Aken, Monica Bari, Sergio Oddi, Chris G Kruse, Mauro Maccarrone, Wytse J Wadman, Taco R Werkman.   

Abstract

The endocannabinoid (eCB) system is widely expressed throughout the central nervous system (CNS) and the functionality of type-1 cannabinoid receptors in neurons is well documented. In contrast, there is little knowledge about type-2 cannabinoid receptors (CB(2)Rs) in the CNS. Here, we show that CB(2)Rs are located intracellularly in layer II/III pyramidal cells of the rodent medial prefrontal cortex (mPFC) and that their activation results in IP(3)R-dependent opening of Ca(2+)-activated Cl(-) channels. To investigate the functional role of CB(2)R activation, we induced neuronal firing and observed a CB(2)R-mediated reduction in firing frequency. The description of this unique CB(2)R-mediated signaling pathway, controlling neuronal excitability, broadens our knowledge of the influence of the eCB system on brain function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22331871      PMCID: PMC3295302          DOI: 10.1073/pnas.1118167109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

2.  Ultrastructural localization of neuronal brain CB2 cannabinoid receptors.

Authors:  A Brusco; P A Tagliaferro; T Saez; E S Onaivi
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

3.  Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus.

Authors:  Alicia Brusco; Patricia Tagliaferro; Trinidad Saez; Emmanuel S Onaivi
Journal:  Synapse       Date:  2008-12       Impact factor: 2.562

Review 4.  Cannabinoid signalling.

Authors:  Dirk G Demuth; Areles Molleman
Journal:  Life Sci       Date:  2005-08-18       Impact factor: 5.037

5.  Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Jian-Ping Gong; Sejal Patel; Paul A Meozzi; Lester Myers; Alex Perchuk; Zoila Mora; Patricia A Tagliaferro; Eileen Gardner; Alicia Brusco; B Emmanuel Akinshola; Qing-Rong Liu; Sanika S Chirwa; Bruce Hope; Javier Lujilde; Toshiya Inada; Shinya Iwasaki; David Macharia; Lindsey Teasenfitz; Tadao Arinami; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

6.  Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.

Authors:  Mauro Maccarrone; Silvia Rossi; Monica Bari; Valentina De Chiara; Filomena Fezza; Alessandra Musella; Valeria Gasperi; Chiara Prosperetti; Giorgio Bernardi; Alessandro Finazzi-Agrò; Benjamin F Cravatt; Diego Centonze
Journal:  Nat Neurosci       Date:  2008-01-20       Impact factor: 24.884

7.  IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei.

Authors:  Susan Currie; Richard D Rainbow; Marie-Ann Ewart; Susan Kitson; Esperanza Herradon Pliego; Kathleen A Kane; John G McCarron
Journal:  J Mol Cell Cardiol       Date:  2008-07-22       Impact factor: 5.000

Review 8.  Cannabinoid modulation of executive functions.

Authors:  Tommy Pattij; Joost Wiskerke; Anton N M Schoffelmeer
Journal:  Eur J Pharmacol       Date:  2008-03-18       Impact factor: 4.432

9.  Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.

Authors:  Jian-Ping Gong; Emmanuel S Onaivi; Hiroki Ishiguro; Qing-Rong Liu; Patricia A Tagliaferro; Alicia Brusco; George R Uhl
Journal:  Brain Res       Date:  2006-02-09       Impact factor: 3.252

10.  Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats.

Authors:  M D Jhaveri; S J R Elmes; D Richardson; D A Barrett; D A Kendall; R Mason; V Chapman
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

View more
  65 in total

1.  Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.

Authors:  Hai-Ying Zhang; Ming Gao; Qing-Rong Liu; Guo-Hua Bi; Xia Li; Hong-Ju Yang; Eliot L Gardner; Jie Wu; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  Xie2-64, a novel CB2 receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents.

Authors:  Chloe J Jordan; Zhi-Wei Feng; Ewa Galaj; Guo-Hua Bi; Ying Xue; Ying Liang; Terence McGuire; Xiang-Qun Xie; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2020-07-24       Impact factor: 5.250

3.  Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.

Authors:  Patricia Del Cerro; Carolina Alquézar; Fernando Bartolomé; Pedro González-Naranjo; Concepción Pérez; Eva Carro; Juan A Páez; Nuria E Campillo; Ángeles Martín-Requero
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

4.  Human urothelial cell lines as potential models for studying cannabinoid and excitatory receptor interactions in the urinary bladder.

Authors:  Evangelia Bakali; Ruth A Elliott; Anthony H Taylor; David G Lambert; Jonathon M Willets; Douglas G Tincello
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-03-21       Impact factor: 3.000

5.  Intracellular GPCRs Play Key Roles in Synaptic Plasticity.

Authors:  Yuh-Jiin I Jong; Steven K Harmon; Karen L O'Malley
Journal:  ACS Chem Neurosci       Date:  2018-02-16       Impact factor: 4.418

6.  Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission.

Authors:  Jimok Kim; Yong Li
Journal:  J Physiol       Date:  2015-01-05       Impact factor: 5.182

7.  Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors.

Authors:  Jian Zhang; Chu Chen
Journal:  Mol Neurobiol       Date:  2017-07-21       Impact factor: 5.590

8.  Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.

Authors:  Andrea Manterola; Ana Bernal-Chico; Raffaela Cipriani; Manuel Canedo-Antelo; Álvaro Moreno-García; Mar Martín-Fontecha; Fernando Pérez-Cerdá; María Victoria Sánchez-Gómez; Silvia Ortega-Gutiérrez; J Mark Brown; Ku-Lung Hsu; Benjamin Cravatt; Carlos Matute; Susana Mato
Journal:  Biochem Pharmacol       Date:  2018-08-01       Impact factor: 5.858

9.  Cannabinoid 2 receptor- and beta Arrestin 2-dependent upregulation of serotonin 2A receptors.

Authors:  J M Franklin; T Vasiljevik; T E Prisinzano; G A Carrasco
Journal:  Eur Neuropsychopharmacol       Date:  2012-07-28       Impact factor: 4.600

10.  Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.

Authors:  Jade M Franklin; Gonzalo A Carrasco
Journal:  Synapse       Date:  2012-12-08       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.